These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32873150)

  • 1. TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
    Totzke J; Scarneo SA; Yang KW; Haystead TAJ
    Open Biol; 2020 Sep; 10(9):200099. PubMed ID: 32873150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.
    Fechtner S; Fox DA; Ahmed S
    Rheumatology (Oxford); 2017 Jul; 56(7):1060-1068. PubMed ID: 27550296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
    Geurts J; van den Brand BT; Wolf A; Abdollahi-Roodsaz S; Arntz OJ; Kracht M; van den Berg WB; van de Loo FA
    Rheumatology (Oxford); 2011 Jul; 50(7):1216-25. PubMed ID: 21335610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.
    Chen DP; Wong CK; Leung PC; Fung KP; Lau CB; Lau CP; Li EK; Tam LS; Lam CW
    J Ethnopharmacol; 2011 Sep; 137(1):457-68. PubMed ID: 21679760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.
    Singh AK; Umar S; Riegsecker S; Chourasia M; Ahmed S
    Arthritis Rheumatol; 2016 Feb; 68(2):347-58. PubMed ID: 26473505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
    Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
    J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of mRNA for transforming growth factor β activated kinase 1 in CD34+ cells of the bone marrow in rheumatoid arthritis.
    Hirohata S; Nagai T; Tomita T
    Clin Exp Rheumatol; 2022 Nov; 40(11):2097-2102. PubMed ID: 35084325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses.
    Xu YR; Lei CQ
    Front Immunol; 2020; 11():608976. PubMed ID: 33469458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract.
    Yang Y; Yu T; Jang HJ; Byeon SE; Song SY; Lee BH; Rhee MH; Kim TW; Lee J; Hong S; Cho JY
    J Ethnopharmacol; 2012 Jan; 139(2):616-25. PubMed ID: 22182430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.
    Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice.
    Scarneo SA; Eibschutz LS; Bendele PJ; Yang KW; Totzke J; Hughes P; Fox DA; Haystead TAJ
    Arthritis Res Ther; 2019 Dec; 21(1):292. PubMed ID: 31847895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells.
    Yang J; Li Y; Wang L; Zhang Z; Li Z; Jia Q
    Biofactors; 2020 Sep; 46(5):813-820. PubMed ID: 32525617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells.
    Lee SY; Lee JH; Shin KK; Kim DS; Kim YS; Bae YC; Jung JS
    Stem Cells Dev; 2015 Apr; 24(7):836-45. PubMed ID: 25350220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid inhibits inflammation via free fatty acid receptor FFA4, disruption of TAB2 interaction with TAK1/TAB1 and downregulation of ERK-dependent Egr-1 expression in EA.hy926 cells.
    Liu KL; Yang YC; Yao HT; Chia TW; Lu CY; Li CC; Tsai HJ; Lii CK; Chen HW
    Mol Nutr Food Res; 2016 Feb; 60(2):430-43. PubMed ID: 26577385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Biological Role of α-Mangostin via TAK1-NF-κB Pathway against Inflammatory.
    Zou W; Yin P; Shi Y; Jin N; Gao Q; Li J; Liu F
    Inflammation; 2019 Feb; 42(1):103-112. PubMed ID: 30132203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype.
    Fu J; Zang Y; Zhou Y; Chen C; Shao S; Hu M; Shi G; Wu L; Zhang D; Zhang T
    Biomed Pharmacother; 2020 Jun; 126():110084. PubMed ID: 32171166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.
    Totzke J; Gurbani D; Raphemot R; Hughes PF; Bodoor K; Carlson DA; Loiselle DR; Bera AK; Eibschutz LS; Perkins MM; Eubanks AL; Campbell PL; Fox DA; Westover KD; Haystead TAJ; Derbyshire ER
    Cell Chem Biol; 2017 Aug; 24(8):1029-1039.e7. PubMed ID: 28820959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling.
    Liu J; Tang J; Zuo Y; Yu Y; Luo P; Yao X; Dong Y; Wang P; Liu L; Zhou H
    Pharmacol Res; 2016 Sep; 111():303-315. PubMed ID: 27343699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.